Home » Newsletters » BioWorld

BioWorld

Sep. 24, 2009

View Archived Issues

Nexavar Continues to Wow in Breast Cancer Combo Study

The data just keep getting better for Nexavar in breast cancer. (BioWorld Today) Read More

No-Vote Panel: Exalgo Approval Needs Tight Abuse Safeguards

Direct RNA Sequencing May Get at 'True Transcriptome' of Cell

Pair of Phase III Trials Upcoming, Spectrum Adds $50M to Coffers

DxS Acquisition Boosts Qiagen's Companion Diagnostics Portfolio

Clinic Roundup

Appointments And Advancements

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.